Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ESOMEPRAZOLE Cause Ischaemic stroke? 131 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 131 reports of Ischaemic stroke have been filed in association with ESOMEPRAZOLE (Esomeprazole Magnesium). This represents 0.2% of all adverse event reports for ESOMEPRAZOLE.

131
Reports of Ischaemic stroke with ESOMEPRAZOLE
0.2%
of all ESOMEPRAZOLE reports
51
Deaths
89
Hospitalizations

How Dangerous Is Ischaemic stroke From ESOMEPRAZOLE?

Of the 131 reports, 51 (38.9%) resulted in death, 89 (67.9%) required hospitalization, and 16 (12.2%) were considered life-threatening.

Is Ischaemic stroke Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ESOMEPRAZOLE. However, 131 reports have been filed with the FAERS database.

What Other Side Effects Does ESOMEPRAZOLE Cause?

Chronic kidney disease (35,281) Acute kidney injury (18,678) Renal failure (14,633) End stage renal disease (10,231) Renal injury (9,440) Gastrooesophageal reflux disease (4,746) Drug ineffective (4,420) Tubulointerstitial nephritis (4,024) Off label use (3,180) Pain (2,898)

What Other Drugs Cause Ischaemic stroke?

RIVAROXABAN (1,724) DABIGATRAN ETEXILATE (1,581) ASPIRIN (735) APIXABAN (728) CLOPIDOGREL BISULFATE (368) CELECOXIB (263) WARFARIN (258) DEXAMETHASONE (255) PREDNISONE (249) ATORVASTATIN (241)

Which ESOMEPRAZOLE Alternatives Have Lower Ischaemic stroke Risk?

ESOMEPRAZOLE vs ESOMEPRAZOLE\ESOMEPRAZOLE\ESOMEPRAZOLE ESOMEPRAZOLE vs ESOMEPRAZOLE\NAPROXEN ESOMEPRAZOLE vs ESTAZOLAM ESOMEPRAZOLE vs ESTRADIOL ESOMEPRAZOLE vs ESTRADIOL CYPIONATE

Related Pages

ESOMEPRAZOLE Full Profile All Ischaemic stroke Reports All Drugs Causing Ischaemic stroke ESOMEPRAZOLE Demographics